In the News December 9, 2015

Cathy Burgess Discusses FDA Quality Metrics Initiative with The Gray Sheet (Audio)

Alston & Bird health care partner Cathy Burgess spoke about how the Food & Drug Administration’s (FDA) quality metrics initiative for pharmaceutical companies may also impact expectations for device manufacturers down the line. Click here to listen.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.